Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Genmark Diagnostics (GNMK)

Genmark Diagnostics (GNMK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 314,213
  • Shares Outstanding, K 58,080
  • Annual Sales, $ 70,760 K
  • Annual Income, $ -50,500 K
  • 60-Month Beta 1.17
  • Price/Sales 4.63
  • Price/Cash Flow N/A
  • Price/Book 37.63

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.16
  • Number of Estimates 4
  • High Estimate -0.15
  • Low Estimate -0.18
  • Prior Year -0.21
  • Growth Rate Est. (year over year) +23.81%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.14 +6.03%
on 10/16/19
6.23 -12.52%
on 11/07/19
+0.24 (+4.61%)
since 10/14/19
3-Month
5.14 +6.03%
on 10/16/19
6.58 -17.17%
on 08/16/19
-1.07 (-16.41%)
since 08/14/19
52-Week
3.58 +52.23%
on 12/21/18
8.37 -34.89%
on 02/22/19
+0.91 (+20.04%)
since 11/14/18

Most Recent Stories

More News
GenMark Diagnostics to Participate in Upcoming Investor Conferences

GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in two upcoming investor...

GNMK : 5.45 (+0.74%)
Genmark Diagnost Shares Down 15.7% Since SmarTrend's Sell Call (GNMK)

SmarTrend identified a Downtrend for Genmark Diagnost (NASDAQ:GNMK) on May 20th, 2019 at $6.79. In approximately 6 months, Genmark Diagnost has returned 15.70% as of today's recent price of $5.72.

GNMK : 5.45 (+0.74%)
GenMark Diagnostics (GNMK) Reports Q3 Loss, Tops Revenue Estimates

GenMark Diagnostics (GNMK) delivered earnings and revenue surprises of -5.26% and 1.25%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

GNMK : 5.45 (+0.74%)
GenMark Diagnostics Reports Third Quarter 2019 Results

GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended September 30, 2019.

GNMK : 5.45 (+0.74%)
Genmark Diagnost Shares Down 14.8% Since SmarTrend's Sell Call (GNMK)

SmarTrend identified a Downtrend for Genmark Diagnost (NASDAQ:GNMK) on May 20th, 2019 at $6.79. In approximately 5 months, Genmark Diagnost has returned 14.81% as of today's recent price of $5.78.

GNMK : 5.45 (+0.74%)
GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019

GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Wednesday, November 6, 2019. Management will hold a conference...

GNMK : 5.45 (+0.74%)
Downtrend Call Working As Genmark Diagnost Stock Falls 19.7% (GNMK)

SmarTrend identified a Downtrend for Genmark Diagnost (NASDAQ:GNMK) on May 20th, 2019 at $6.79. In approximately 5 months, Genmark Diagnost has returned 19.68% as of today's recent price of $5.45.

GNMK : 5.45 (+0.74%)
Genmark Diagnost Shares Down 13.3% Since SmarTrend's Sell Call (GNMK)

SmarTrend identified a Downtrend for Genmark Diagnost (NASDAQ:GNMK) on May 20th, 2019 at $6.79. In approximately 5 months, Genmark Diagnost has returned 13.26% as of today's recent price of $5.89.

GNMK : 5.45 (+0.74%)
Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Invacare Corp (IVC , TNDM, GNMK , NUVA , EW )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

GNMK : 5.45 (+0.74%)
IVC : 10.02 (+1.73%)
TNDM : 62.57 (-0.11%)
Downtrend Call Working As Genmark Diagnost Stock Falls 13.9% (GNMK)

SmarTrend identified a Downtrend for Genmark Diagnost (NASDAQ:GNMK) on May 20th, 2019 at $6.79. In approximately 4 months, Genmark Diagnost has returned 13.93% as of today's recent price of $5.84.

GNMK : 5.45 (+0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade GNMK with:

Business Summary

GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor' XT-8 system is the second generation in GenMark Dx's eSensor' platform, utilizing electrochemical detection technology to detect nucleic...

See More

Key Turning Points

2nd Resistance Point 5.62
1st Resistance Point 5.53
Last Price 5.45
1st Support Level 5.37
2nd Support Level 5.30

See More

52-Week High 8.37
Fibonacci 61.8% 6.54
Fibonacci 50% 5.97
Last Price 5.45
Fibonacci 38.2% 5.41
52-Week Low 3.58

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar